1. Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
   Cem Simsek et al, 2019, Journal of Oncology CrossRef
2. Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen
   Li-jie Wang et al, 2016, Acta Pharmacol Sin CrossRef
3. Abiraterone acetate for the treatment of castrate-refractory prostate cancer
   Andrew Caley et al, 2013, Aging Health CrossRef
4. Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
   Kouji Izumi et al, 2014, Clinical Investigation CrossRef
5. Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
   M. Vogelhuber et al, 2015, Cancer Microenvironment CrossRef
6. Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients
   S. Sideris et al, 2016, J Endocrinol Invest CrossRef
7. Corticosteroid switch after progression on abiraterone acetate plus prednisone
   Giandomenico Roviello et al, 2019, Int J Clin Oncol CrossRef
8. Development and validation of a LC-MS/MS method for simultaneous determination of six glucocorticoids and its application to a pharmacokinetic study in nude mice
   Qingyu Yao et al, 2019, Journal of Pharmaceutical and Biomedical Analysis CrossRef
9. Dexamethasone Inhibits Spheroid Formation of Thyroid Cancer Cells Exposed to Simulated Microgravity
   null Melnik et al, 2020, Cells CrossRef
10. PSA response following the 'steroid switch' in patients with castration-resistant prostate cancer treated with abiraterone: A case report.
    Tomonori Kato et al, 0 CrossRef
11. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production
    Chao Han et al, 2020, PLoS ONE CrossRef
12. In Regard to Zelefsky et al
    Kato Rans et al, 2021, International Journal of Radiation Oncology*Biology*Physics CrossRef
13. Low-Dose Docetaxel Combined with Dexamethasone Is Feasible for Patients with Castration-Resistant Prostate Cancer
    Noriyoshi Miura et al, 2016, Chemotherapy CrossRef